[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
date : 4/19/2024
Tags: NCDs, Precision Cancer Medicine
Health and Global Institute (HGPI) hosted the Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine in both on-site and online (Hybrid) format on April 4th, 2024.
In the field of oncology, “Cancer Genomic Medicine” has already been actively adopted into routine clinical practice in some countries. There are high expectations that cancer genomic medicine has the potential to fundamentally change the cancer treatment strategy for individual patients in the future.
At this meeting, since ensuring equitable patient access to cancer genomic medicine, including cancer genetic panel testing and subsequent treatment, has become a global topic of discussion, multi-stakeholders were invited, discussing about the latest initiatives in the UK and Japan.
The panel discussion at this meeting focused on the following issues
- Geographic and informational barriers to participation in tests and clinical trials.
- How industry-government-academia-industry collaboration can help remove bottlenecks to patient access.
- Assessment and institutional design measures to ensure access to appropriate tests and treatments at the right time.
- Actions to disseminate and scale up advanced technologies for general use.
[Event Overview]
- Date & Time: Thursday, April 4, 2024; from 15:30 to 19:00 JST / from 7:30 to 11:00 GMT (Open: 15:00 JST / 7:00 GMT)
- Format: Hybrid (In-Person and Online (Zoom Webinars))
- Venue: Global Business Hub Tokyo Field
(Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, JAPAN 100-0004) - Languages: Japanese and English (with simultaneous interpretation)
- Participation fee: Free
- Hosted by: Health and Global Policy Institute
- Supported by: The British Embassy Tokyo
- Sponsored by: AstraZeneca K.K., National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP), Philips Japan, Ltd.
[Program] (Titles omitted; in no particular order)
15:30-15:40 | Opening Remarks |
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute) | |
15:40-16:00 | Keynote Speech 1: Genomic Cancer Medicine in Japan |
Hitoshi Nakagama (President, National Cancer Center) | |
16:00-16:20 | Keynote Speech 2: Genomic Cancer Medicine in the UK |
Dame Sue Hill (Chief Scientific Officer, England and Senior Responsible Officer for Genomics, NHS) | |
– Break (10 mins) – | |
16:30-17:10 | Round Table Discussion 1 “Tackling Regional Disparities in Patient Access to Genomic Cancer Medicine” |
Panelists Moderator |
|
17:10-17:50 | Round Table Discussion 2 “Optimizing Financial and Institutional Support for Innovation” |
Panelists Moderator
|
|
17:50-18:00 | Closing Remarks |
Margaret Tongue (Minister-Counsellor Economic Diplomacy, British Embassy Tokyo) | |
18:00-19:00 | Networking Reception |
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)